poisar

Stock

Dyadic International, Inc. DYAI

$0.81+5.18%

Overview

DYAI market data

Price History

DYAI price chart

Valuation & Profitability

Provider-backed
P/E (TTM)
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
-$0.23
Diluted earnings per share over the trailing twelve months.
Beta
1.03
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
-191.5%
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$0.65 – $1.60
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $35.9M · P/B 27.60 · P/S 9.43.

Company News

10 captured
8-K filing — DYADIC INTERNATIONAL INC (DYAI)SEC EDGAR · Aug 14, 2026, 1:17 PM
Dyadic International shares are trading lower after the company announced a $2.9 million offering and concurrent private placement.Benzinga · Aug 13, 2026, 4:16 PM
Dyadic International Announces Definitive Agreements For $2.9M Registered Direct Offering And Concurrent Private Placement Of Warrants With Institutional InvestorBenzinga · Aug 13, 2026, 12:07 PM
Dyadic International shares are trading lower after the company reported worse-than-expected Q2 financial results.Benzinga · Aug 12, 2026, 4:32 PM
Dyadic International Q2 EPS $(0.06) Misses $(0.04) Estimate, Sales $961.138K Miss $993.333K EstimateBenzinga · Aug 12, 2026, 12:38 PM
Dyadic International Inks New Development, Commercial License Agreement With European Biotechnology Firm For Additional Precision Fermented Dairy ProteinsBenzinga · Aug 4, 2026, 11:27 AM
Dyadic International Regains Nasdaq ComplianceBenzinga · Jul 24, 2026, 11:30 AM
Dyadic Expands Bio industrial Pipeline with New Proprietary Industrial Enzyme ProgramGlobenewswire Inc · Jul 16, 2026, 12:30 PM
Dyadic Announces Japan Patent Office Allowance Of Claims Covering Its Proprietary Thermothelomyces Heterothallica Recombinant Protein Expression TechnologyBenzinga · Jun 29, 2026, 11:30 AM
Dyadic Highlights Increasing Interest In Proprietary C1 Protein Production Platform As Global Infectious Disease Preparedness Efforts Intensify In Response To Ongoing Bundibugyo Ebola Virus OutbreakBenzinga · Jun 15, 2026, 11:40 AM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock